Avita Medical (ASX:AVH) reported Friday a March quarter net loss of $0.35 per share, compared with $0.53 a year earlier.
Revenue for the three months ended March 31 was $19.3 million, compared with $18.5 million a year earlier.
The company reaffirmed its full-year guidance, with revenue expected in the range of $80 million to $85 million.
Its shares rose 1% in recent trading on Friday.